archives of general psychiatry-arkiv

  • Et nyt studie har undersøgt om småbørn helt ned til tre års alderen kan have depression. Noget tyder på at det er sandsynligt. Studiet er det første til at vise...

    Depression hos småbørn

    Et nyt studie har undersøgt om småbørn helt ned til tre års alderen kan have depression. Noget tyder på at det er sandsynligt. Studiet er det første til at vise...

    Fortsæt læsning …

  • Forskere ved University of Minnesota Medical School har opdaget, at en anti-oxidant kan hjælpe til at stoppe trangen hos dem med trikotillomani, en lidelse karakteriseret ved kompulsiv (tvangsmæssig) hårudtrækken. Undersøgelsen...

    Mulig ny medicinsk behandling af trikotillomani – kompulsiv (tvangsmæssig) hårudtrækken

    Forskere ved University of Minnesota Medical School har opdaget, at en anti-oxidant kan hjælpe til at stoppe trangen hos dem med trikotillomani, en lidelse karakteriseret ved kompulsiv (tvangsmæssig) hårudtrækken. Undersøgelsen...

    Fortsæt læsning …

  • According to a National Institute of Mental Health press release on 7 August 2006, a study of 17 patients led by Dr Carlos Zarate Jr. of the NIMH showed that ketamine significantly improved treatment-resistant major depression within two hours of injection. The improvement lasted up to one week after the single dose. The patients in the study were previously treatment resistant, having tried an average of six other treatments that failed. The importance of these findings was articulated by NIMH director Dr Thomas Insel:

    Ketamine treatment for depression?

    According to a National Institute of Mental Health press release on 7 August 2006, a study of 17 patients led by Dr Carlos Zarate Jr. of the NIMH showed that ketamine significantly improved treatment-resistant major depression within two hours of injection. The improvement lasted up to one week after the single dose. The patients in the study were previously treatment resistant, having tried an average of six other treatments that failed. The importance of these findings was articulated by NIMH director Dr Thomas Insel: "This is the first report of any medication or other treatment that results in such a pronounced, rapid, prolonged response." The researchers apparently attribute the effect to ketamine being an NMDA receptor antagonist.

    Fortsæt læsning …

  • Studies of DNA from OCD patients and their relatives lead two teams of researchers to consistent genetic association. Obsessive-compulsive disorder tends to run in families, causing members of several generations to experience severe anxiety and disturbing thoughts that they ease by repeating certain behaviors. In fact, close relatives of people with OCD are up to nine times more likely to develop OCD themselves. Now, new research is shedding new light on one of the genetic factors that may contribute to that pattern. And while no one gene

    New genetic findings add to understanding of OCD

    Studies of DNA from OCD patients and their relatives lead two teams of researchers to consistent genetic association. Obsessive-compulsive disorder tends to run in families, causing members of several generations to experience severe anxiety and disturbing thoughts that they ease by repeating certain behaviors. In fact, close relatives of people with OCD are up to nine times more likely to develop OCD themselves. Now, new research is shedding new light on one of the genetic factors that may contribute to that pattern. And while no one gene "causes" OCD, the research is helping scientists confirm the importance of a particular gene that has been suspected to play a major role in OCD's development.

    Fortsæt læsning …